XML 35 R2.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 266,319 $ 177,849
Prepaid expenses and other current assets 18,430 9,948
Total current assets 284,749 187,797
Non-current assets:    
Property and equipment, net 17,743 13,369
Operating lease right of use assets 11,048 14,740
Deferred tax assets 26 4
Restricted cash 33  
Other assets 3,507 3,008
Total non-current assets 32,357 31,121
TOTAL ASSETS 317,106 218,918
Current liabilities:    
Accounts payable 3,722 6,314
Income taxes payable   7
Accrued expenses and other liabilities 10,906 6,590
Operating lease liabilities—current 4,482 3,712
Total current liabilities 19,110 16,623
Non-current liabilities:    
Operating lease liabilities-non-current 7,777 12,271
Other long-term liability 691 652
Total non-current liabilities 8,468 12,923
Total liabilities 27,578 29,546
Commitments and contingencies (Note 13)
Shareholders' equity:    
Ordinary shares, £0.001 par value; 40,603,489 and 4,389,920 shares authorized, issued and outstanding at December 31,2021 and 2020, respectively 54 6
Deferred shares, £92,451.851 par value, one share authorized, issued and outstanding at December 31, 2021; Deferred shares, £0.001 par value; 30,521 shares issued and outstanding at December 31,2020 128  
Additional paid in capital 401,821 234,922
Accumulated other comprehensive income 6,636 12,322
Accumulated deficit (119,111) (58,012)
Total shareholders’ equity 289,528 189,372
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 317,106 218,918
Convertible Preferred Shares    
Shareholders' equity:    
Convertible preferred shares, £0.001 par value; no shares authorized, issued and outstanding as of December 31, 2021; 104,854,673 shares authorized, issued and outstanding at December 31, 2020   $ 134